Data Transfer Agreement Clinical Trial Template for the United Arab Emirates

A Data Transfer Agreement Clinical Trial is a specialized legal contract that governs how sensitive medical research data is shared between different organizations participating in clinical trials within the United Arab Emirates. This document ensures compliance with the UAE's strict data protection framework while enabling legitimate medical research activities that advance healthcare outcomes.

When do you need this document?

You require this agreement whenever clinical trial data containing personal or health information needs to be transferred between different entities involved in your research project. This includes situations where pharmaceutical companies share patient data with contract research organizations, when research sites transfer clinical data to central laboratories for analysis, or when sponsors need to provide trial data to regulatory authorities or data monitoring committees. The agreement becomes particularly critical when your clinical trial involves multiple jurisdictions and requires cross-border data transfers, as the UAE has specific requirements for international data sharing. You also need this document when engaging third-party service providers such as clinical data management companies, biostatistics firms, or electronic data capture system providers who will process or store your clinical trial data.

Key legal considerations

Your agreement must clearly define the roles and responsibilities of each party, distinguishing between data controllers and data processors under UAE law. Essential clauses include detailed data security measures, encryption requirements, and access controls that meet UAE healthcare standards. You should specify the exact types of clinical trial data being transferred, the purposes for which it will be used, and retention periods that align with regulatory requirements. The agreement must address data subject rights, including procedures for handling access requests, corrections, and deletion requests from trial participants. Breach notification procedures are crucial, requiring immediate notification to relevant parties and potentially to UAE regulatory authorities within specified timeframes. You should also include provisions for data localization requirements and specify approved methods for cross-border transfers when applicable.

Legal requirements in United Arab Emirates

Under Federal Decree-Law No. 45 of 2021, your agreement must ensure that personal data transfers comply with UAE data protection principles, including lawfulness, fairness, and transparency in processing. Federal Law No. 2 of 2019 on healthcare ICT requires specific technical and organizational measures for electronic health information exchange, including secure transmission protocols and audit trail requirements. Your agreement must incorporate MOHAP Guidelines for Clinical Trials, which establish additional requirements for data handling in clinical research contexts. For cross-border transfers, you must ensure adequate protection levels in destination countries or implement appropriate safeguards such as binding corporate rules or standard contractual clauses approved by UAE authorities. The agreement should address data localization requirements where certain categories of health data must remain within UAE borders, and include provisions for regulatory inspections and cooperation with UAE healthcare authorities when required.